Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)

Historical Holders from Q2 2018 to Q3 2025

Symbol
ENTX on Nasdaq
Type / Class
Equity / Ordinary shares, par value NIS 0.0000769 per share
Shares outstanding
45,504,462
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9,194,576
Holdings value
$17,653,167
% of all portfolios
0%
Number of holders
21
Number of buys
8
Number of sells
8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OPKO HEALTH, INC. 8.1% $8,660,281 3,685,226 OPKO HEALTH, INC. 16 Mar 2025
Point72 Asset Management, L.P. 2.6% -60% $2,271,583 -$2,915,412 1,183,116 -56% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2025 Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,194,576 shares of 45,504,462 outstanding shares and own 20% of the company stock as of 30 Sep 2025.

Top 23 institutional shareholders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) own 20% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Knoll Capital Management, LLC 13% 5,881,879 0% 6.1% $11,293,207
Point72 Asset Management, L.P. 2.6% 1,178,443 -56% 0% $2,262,611
MARSHALL WACE, LLP 1.4% 627,330 0% $1,204,474
Schonfeld Strategic Advisors LLC 1.2% 566,956 -6.2% 0.01% $1,088,554
Parkman Healthcare Partners LLC 0.62% 280,822 -21% 0.06% $539,178
NORTHERN TRUST CORP 0.33% 148,668 -26% 0% $285,443
BESSEMER GROUP INC 0.31% 140,843 0% 0% $270,000
RENAISSANCE TECHNOLOGIES LLC 0.19% 88,400 +37% 0% $169,728
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.15% 67,177 +37% 0% $128,980
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC 0.1% 47,328 0% 0% $90,870
CITADEL ADVISORS LLC 0.09% 39,978 +243% 0% $76,758
JANE STREET GROUP, LLC 0.07% 30,528 +200% 0% $58,614
GEODE CAPITAL MANAGEMENT, LLC 0.05% 21,136 0% 0% $40,581
BANK OF AMERICA CORP /DE/ 0.05% 21,000 -10% 0% $40,320
HighTower Advisors, LLC 0.04% 18,140 -73% 0% $34,829
XTX Topco Ltd 0.02% 10,771 0% $20,680
UBS Group AG 0.02% 10,452 -33% 0% $20,068
PNC Financial Services Group, Inc. 0.02% 10,000 0% 0% $19,200
Cubist Systematic Strategies, LLC 0.01% 4,673 +473% 0% $8,972
GROUP ONE TRADING LLC 0% 51 0% 0% $98
SBI Securities Co., Ltd. 0% 1 0% $2
NewEdge Advisors, LLC 0% 0 -100% $0
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.05% 21,100 0% $40,512

Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 9,194,576 $17,653,167 -$1,951,360 $1.92 21
2025 Q2 10,211,002 $19,401,301 +$12,863 $1.90 19
2025 Q1 10,222,258 $17,377,838 +$4,637,662 $1.70 18
2024 Q4 7,494,222 $15,902,006 +$4,661,706 $2.12 14
2024 Q3 5,323,228 $10,112,228 +$57,454 $1.90 17
2024 Q2 5,292,989 $9,745,202 +$1,916,835 $1.84 14
2024 Q1 4,259,308 $7,113,387 +$404,057 $1.67 14
2023 Q4 4,062,589 $2,437,015 +$887,868 $0.6000 9
2023 Q3 2,579,003 $1,870,234 +$4,206 $0.7250 11
2023 Q2 2,569,162 $2,166,115 -$314,934 $0.8438 10
2023 Q1 2,830,846 $3,283,550 -$215,433 $1.16 8
2022 Q4 566,752 $413,272 -$1,176,817 $0.7300 10
2022 Q3 4,663,496 $4,850,000 -$254,655 $1.04 8
2022 Q2 4,916,394 $6,538,000 -$45,964 $1.33 9
2022 Q1 4,949,328 $14,203,000 -$2,021,499 $2.86 10
2021 Q4 5,655,346 $15,920,000 -$38,159 $2.82 10
2021 Q3 5,665,990 $26,717,000 +$2,489,496 $4.71 13
2021 Q2 5,111,468 $30,566,000 +$18,924,636 $5.98 14
2021 Q1 1,986,053 $7,567,000 +$563,572 $3.81 7
2020 Q4 1,857,733 $2,008,000 -$82,677 $1.09 5
2020 Q3 1,905,237 $2,363,000 -$160,746 $1.24 5
2020 Q2 1,950,079 $3,422,000 -$82,244 $1.83 5
2020 Q1 1,990,244 $3,781,000 +$137,000 $1.99 3
2019 Q4 1,921,509 $3,990,000 +$1,633,552 $2.07 3
2019 Q3 1,054,649 $2,624,000 -$28,428 $2.49 5
2019 Q2 1,065,733 $3,492,000 -$119,087 $3.26 6
2019 Q1 1,087,864 $4,669,000 +$276,172 $4.32 7
2018 Q4 1,025,992 $3,100,000 +$768,525 $3.05 5
2018 Q3 768,625 $4,108,000 +$250,730 $5.63 4
2018 Q2 725,479 $4,571,000 +$4,571,000 $6.30 3